Ensure Safe Use of OTC Primatene Mist for Asthma

January 2019

Primatene Mist (epinephrine) will return to OTC shelves for relieving mild symptoms of intermittent asthma in patients age 12 and up.

It was withdrawn in 2011 due to chlorofluorocarbon (CFC) propellant regulations, NOT safety issues. But many of us were happy to see it go.

Now Primatene Mist is back with an HFA propellant.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote